Loading...
Ambev SA (ABEV) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock lacks strong positive catalysts, has declining financial performance, and hedge funds are selling heavily. While technical indicators show some bullish trends, the lack of significant upside potential and weak sentiment make it a hold rather than a buy.
The MACD is slightly positive but contracting, indicating weakening momentum. RSI is neutral at 68.328, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key support is at 3.033, and resistance is at 3.216. The stock is trading below its previous close, with a slight pre-market gain of 0.94%.

Technical indicators suggest a bullish trend in moving averages.
Hedge funds are heavily selling, with a 9796.69% increase in selling activity over the last quarter. Financial performance in Q4 2025 shows declines across revenue (-8.24% YoY), net income (-10.94% YoY), EPS (-9.68% YoY), and gross margin (-1.96%). No significant insider or congress trading activity. No recent news or event-driven catalysts.
In Q4 2025, revenue dropped to 24.81 billion (-8.24% YoY), net income dropped to 4.35 billion (-10.94% YoY), EPS dropped to 0.28 (-9.68% YoY), and gross margin dropped to 52.63% (-1.96% YoY).
Barclays raised the price target to $3 from $2.50 and maintained an Equal Weight rating, indicating moderate sentiment.